Targeting Force-Regulated FimH Adhesin: Assays, Mannosides, and Biologics for Anti-Virulence Therapy of UPEC Infection
ACS Infectious Diseases · 17.10.2026
DOI: 10.1021/acsinfecdis.6c00689 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Infectious Diseases, online erschienen am 17.10.2026. Verfasst von Mohor Mitra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Pathogenesis and Immunology, Texas A&M University, Bryan, Texas77807, United States. Hauptthemen laut MEDLINE: Fimbriae Proteins, Adhesins, Escherichia coli, Mannosides, Uropathogenic Escherichia coli. Die Arbeit nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, Texas A and M University.
Abstract (Originalsprache)
Urinary tract infections (UTIs) are among the most common bacterial infections, and recurrent UTIs caused by uropathogenic Escherichia coli (UPEC) drive antibiotic use and antimicrobial resistance. FimH, the mannose-binding adhesin at the tip of type 1 pili, is a central UPEC virulence factor. Under shear force, FimH switches from a low-affinity, tense state to a high-affinity, relaxed state, strengthening adhesion during urine flow. This catch-bond behavior makes FimH a promising anti-virulence target, though a difficult one to drug. Here, we review strategies to target FimH, including monovalent and multivalent mannosides, vaccines, conformation-selective monoclonal antibodies, and de novo engineered miniproteins, together with the assays used to quantify FimH-ligand binding and UPEC adhesion. Clinical translation has been limited by assay-dependent potency, urinary pharmacokinetics, and intracellular reservoirs. We posit that effective FimH-targeted therapy requires alignment among inhibitor mechanism, FimH conformational state, bladder lumen exposure, and infection stage, which in turn defines realistic roles in prevention, early intervention, and combination therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbial Pathogenesis and Immunology, Texas A&M University, Bryan, Texas77807, United States.
- Genetics and Genomics Interdisciplinary Program, Texas A&M University, College Station, Texas77843, United States.
- Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas77843, United States.
ORCID-Profile: Zhilei Chen
Förderung
- National Institute of Allergy and Infectious Diseases
- Texas A and M University
Zitieren
APA
Mitra, M., & Chen, Z. (2026). Targeting Force-Regulated FimH Adhesin: Assays, Mannosides, and Biologics for Anti-Virulence Therapy of UPEC Infection. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.6c00689
Vancouver
Mitra M, Chen Z. Targeting Force-Regulated FimH Adhesin: Assays, Mannosides, and Biologics for Anti-Virulence Therapy of UPEC Infection. ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.6c00689
BibTeX
@article{Mitra2026,
author = {Mitra, Mohor and Chen, Zhilei},
title = {Targeting Force-Regulated FimH Adhesin: Assays, Mannosides, and Biologics for Anti-Virulence Therapy of UPEC Infection},
journal = {ACS Infectious Diseases},
year = {2026},
doi = {10.1021/acsinfecdis.6c00689}
}
EUVIMED